OUR MITHRAX PROJECT

Transcatheter mitral valve repair - TMVr

Mitral regurgitation is one of the most prevalent valvular heart disease in western markets. TMVr options are still limited.

MithraX effectively addresses structural mitral regurgitation (MR) while also preventing functional MR. By preserving the native structures and dynamics of the mitral apparatus, it enhances the expected survival rate. MithraX offers a versatile solution suitable for various patient profiles and types of structural regurgitation.

Trans-femoral, trans-septal access

Prevents dilatation of the annulus

Restores leaflet coaptation

To learn more about MithraX simply contact us - we’re happy to answer any questions you may have.